Senior investor and corporate director with a track record of scaling growth-stage companies and advising venture and private-equity managers. Elizabeth C. Carr combines operational leadership in finance and strategy with board governance experience across healthcare and technology portfolios. She focuses on scalable business models, capital efficiency and exit readiness, and is active in direct investments, follow-on financings and board-level performance improvement. Known for disciplined valuation approach and hands-on portfolio company support.
Senior investor and corporate director with a track record of scaling growth-stage companies and advising venture and private-equity managers. Elizabeth C. Carr combines operational leadership in finance and strategy with board governance experience across healthcare and technology portfolios. She focuses on scalable business models, capital efficiency and exit readiness, and is active in direct investments, follow-on financings and board-level performance improvement. Known for disciplined valuation approach and hands-on portfolio company support.
Combines operational finance and board experience to favor capital-efficient, scalable growth-stage companies in healthcare and technology. Prioritizes rigorous valuation and milestone-driven capital deployment, blending seed-to-growth direct investments with selective follow-ons to preserve ownership and optionality. Emphasizes measurable KPIs, governance upgrades, and exit-readiness through strategic M&A or IPO paths. Risk discipline centers on downside protection, capital efficiency, and active, hands-on portfolio engagement.
Combines operational finance and board experience to favor capital-efficient, scalable growth-stage companies in healthcare and technology. Prioritizes rigorous valuation and milestone-driven capital deployment, blending seed-to-growth direct investments with selective follow-ons to preserve ownership and optionality. Emphasizes measurable KPIs, governance upgrades, and exit-readiness through strategic M&A or IPO paths. Risk discipline centers on downside protection, capital efficiency, and active, hands-on portfolio engagement.
| Trades 721 | Longs Won 529/721 73% | Profit Factor 9.17 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $764,615.15 |
| Average Win $189,076.76 | Best Trade (Jul 17) $11.93M | Sharpe Ratio -15.57 |
| Average Loss -$56,797.31 | Worst Trade (Mar 30) -$4.33M | Z-Score 14.19 (100%) |
| Commissions $0 | Avg. Trade Length 10m 6d | Expectancy $123,601.28 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 7,692 | 6,923 | 6,154 | 5,385 | 4,615 | 3,846 | 3,077 | 2,308 | 1,538 | 769 |